Clinical Trial Update: Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating stopping antibiotics after 3 days for high-risk febrile neutropenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Neutropenia, Febrile | Phase 4 | Status: RECRUITING